ATLASATLAS fair value
ATLAS has no fair value for this stock today.
MEDICLIN (MED.XETRA)
MEDICLIN stock price today, ATLAS forecast and fair value
Healthcare · Medical Care Facilities · Xetra (Deutsche Börse) · Germany
€5.30▲ +1.92%
Prices as of Oct 27, 2026 · EUR
Chance of rising in 1 month
50%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on MEDICLIN in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On MEDICLIN
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives MEDICLIN a 50% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between €4.99 and €5.64; in 9 out of 10, between €4.47 and €6.29. Estimated annual volatility is 36%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- €246M
- Market cap (USD)
- $275M
- P/E ratio
- 8.5
- Dividend yield
- 0.74%
- 52-week high
- €5.80
- 52-week low
- €3.22
- Revenue (12 months)
- €820M
- Gross margin
- 20.9%
- Operating margin
- 8.3%
- Net margin
- 3.6%
- Beta
- 0.49
What this means
ATLAS does not publish a fair value for MED.XETRA right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks MED.XETRA has traded between €3.22 and €5.80. Today it is 8.6% below that high and 65% above its low.
On the business: net margin is 3.6%; it trades at 8.5 times earnings.
Its beta is 0.49: it tends to move less than the market.
About the company
MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute; Acute; and Nursing Care and Service segments.
Want to see everything about MEDICLIN?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does MEDICLIN do?
MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute; Acute; and Nursing Care and Service segments.
What is the chance MED.XETRA goes up next month?
50%: close to a coin flip. In half of the simulated outcomes, MED.XETRA ends the month between €4.99 and €5.64.
How big is MEDICLIN and what is its P/E ratio?
MEDICLIN's market capitalization is €246M. Its price-to-earnings (P/E) ratio is 8.5: you pay €8.49 for each €1.00 of yearly earnings.
Does MEDICLIN pay a dividend?
Yes. MED.XETRA's current dividend yield is 0.74% at today's price (€5.30).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer